– Functional Antibodies Identified to S1 Spike Protein and ACE2 Cellular Receptor – May 06, 2020 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation...
Biopharma
Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
– First off-the-shelf AdenoVerse™ immunotherapy to enter the clinic – – Immunotherapy designed to activate the immune system to recognize and target HPV+ solid tumors – GERMANTOWN, Md., April 20...
